Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY

v3.8.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
BALANCE at Oct. 31, 2015 $ 14,000 $ 87,249 $ 151,101,117 $ (146,148,765) $ 5,053,601
BALANCE (in Shares) at Oct. 31, 2015 140 8,724,878      
Stock option compensation to employees and consultants     873,561   873,561
Common stock issued upon exercise of stock options   $ 127 33,454   33,581
Common stock issued upon exercise of stock options (in Shares)   12,676      
Common stock issued to consultants   $ 108 31,252   31,360
Common stock issued to consultants (in Shares)   10,833      
Common stock issued to acquire patents   $ 40 11,760   11,800
Common stock issued to acquire patents (in Shares)   4,000      
Net Loss       (5,016,428) (5,016,428)
BALANCE at Oct. 31, 2016 $ 14,000 $ 87,524 152,051,144 (151,165,193) 987,475
BALANCE (in Shares) at Oct. 31, 2016 140 8,752,387      
Stock option compensation to employees and consultants     1,222,772   1,222,772
Common stock issued upon exercise of stock options   $ 402 6,871   7,273
Common stock issued upon exercise of stock options (in Shares)   40,220      
Common stock issued to consultants and directors   $ 2,095 484,329   486,424
Common stock issued to consultants and directors (in Shares)   209,463      
Redemption of convertible preferred stock $ (14,000)   (3,486,000)   (3,500,000)
Redemption of convertible preferred stock (in Shares) (140)        
Common stock issued to repay patent acquisition obligation   $ 9,476 2,842,818   2,852,294
Common stock issued to repay patent acquisition obligation (in Shares)   947,606      
Common stock issued in shareholder rights offering   $ 19,892 4,183,410   4,203,302
Common stock issued in shareholder rights offering (in Shares)   1,989,207      
Common stock issued in registered direct offering   $ 34,254 3,177,534   3,211,788
Common stock issued in registered direct offering (in Shares)   3,425,376      
Common stock issued in-at-the market offering   $ 12,385 3,448,201   3,460,586
Common stock issued in-at-the market offering (in Shares)   1,238,500      
Net Loss       (5,008,991) (5,008,991)
BALANCE at Oct. 31, 2017   $ 166,028 $ 163,931,079 $ (156,174,184) $ 7,922,923
BALANCE (in Shares) at Oct. 31, 2017   16,602,759